Coronally advanced flap with connective tissue graft or xenogeneic acellular dermal matrix in the treatment of multiple gingival recessions: A split‐mouth randomized clinical trial.

Gürlek et al. 2019. J Esthet Restor Dent. [Epub ahead of print]. doi: 10.1111/jerd.12547.

Evaluation of mucoderm® and connective tissue graft (CTG)  in the treatment of multiple Miller class I and II recessions using the modified-coronally advanced flap (M-CAF) in a split-mouth design.

12 patients with bilateral Miller I and II recessions were treated with mucoderm® on one side and CTG on the other side. Both tissue grafts were combined with the M-CAF to treat a total of 82 recessions. Clinical parameters, such as PD, RD, RW, KTW, CAL, CRC, PRC were analysed 6 and 18 months postoperatively.

Most of the analysed parameters showed no significant differences between mucoderm® and CTG. At 6 months, a significant difference was found for KTW, which was higher for CTG. Positive changes were found for both regarding CAL, RD, RW. Also the percentage of complete root coverage was not significantly different between mucoderm® and CTG.

Both tested tissues in combination with the M-CAF were highly effective to treat multiple gingival recessions of Miller class I and II. mucoderm® proofed to be a valid alternative to the autologous connective tissue graft during an observation period of 18 months.

Önder Gürlek


Leave A Comment

Related Posts